Home/Filings/4/0001209191-23-021305
4//SEC Filing

Sauer Dirk 4

Accession 0001209191-23-021305

CIK 0001534133other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 7:58 PM ET

Size

8.1 KB

Accession

0001209191-23-021305

Insider Transaction Report

Form 4
Period: 2023-03-23
Sauer Dirk
Director
Transactions
  • Disposition to Issuer

    Common Stock

    2023-03-23+1,4291,429 total
  • Disposition to Issuer

    Restricted Stock Unit

    2023-03-231,4290 total
    Common Stock (1,429 underlying)
Footnotes (1)
  • [F1]Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the "Merger Agreement"), by and among CalciMedica, Inc. ("Private CalciMedica"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the "Merger"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Dirk Sauer's options and restricted stock units ("RSUs") were fully accelerated and the RSUs were settled on March 23, 2023.

Issuer

CalciMedica, Inc.

CIK 0001534133

Entity typeother

Related Parties

1
  • filerCIK 0001921165

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 7:58 PM ET
Size
8.1 KB